Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin.

Campbell MR, Zhang H, Ziaee S, Ruiz-Saenz A, Gulizia N, Oeffinger J, Amin DN, Ahuja D, Moasser MM, Park CC.

Breast Cancer Res Treat. 2016 Feb;155(3):431-40. doi: 10.1007/s10549-016-3698-y. Epub 2016 Feb 9.

2.

Pre-morbid glycemic control modifies the interaction between acute hypoglycemia and mortality.

Egi M, Krinsley JS, Maurer P, Amin DN, Kanazawa T, Ghandi S, Morita K, Bailey M, Bellomo R.

Intensive Care Med. 2016 Apr;42(4):562-571. doi: 10.1007/s00134-016-4216-8. Epub 2016 Feb 3.

PMID:
26846519
3.

Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib.

Amin DN, Ruiz-Saenz A, Gulizia N, Moasser MM.

Oncotarget. 2015 Dec 1;6(38):41123-33. doi: 10.18632/oncotarget.5660.

4.

A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified Cancers.

Amin DN, Ahuja D, Yaswen P, Moasser MM.

Mol Cancer Ther. 2015 Dec;14(12):2805-17. doi: 10.1158/1535-7163.MCT-15-0403. Epub 2015 Oct 5.

5.

Disentangling multidimensional spatio-temporal data into their common and aberrant responses.

Chang YH, Korkola J, Amin DN, Moasser MM, Carmena JM, Gray JW, Tomlin CJ.

PLoS One. 2015 Apr 22;10(4):e0121607. doi: 10.1371/journal.pone.0121607. eCollection 2015.

6.

Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.

Schuetz P, Raad I, Amin DN.

Curr Opin Crit Care. 2013 Oct;19(5):453-60. doi: 10.1097/MCC.0b013e328363bd38. Review.

PMID:
23817026
7.

Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.

Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E.

Crit Care. 2013 Jun 20;17(3):R115. doi: 10.1186/cc12787.

8.

Influence of membrane lipid composition on a transmembrane bacterial chemoreceptor.

Amin DN, Hazelbauer GL.

J Biol Chem. 2012 Dec 7;287(50):41697-705. doi: 10.1074/jbc.M112.415588. Epub 2012 Oct 15.

9.

Influence of major cardiopulmonary surgery on serum levels of procalcitonin and other inflammatory markers.

Amin DN, Pruitt JC, Schuetz P.

Anaesth Intensive Care. 2012 Sep;40(5):760-6.

10.

HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cells.

Amin DN, Sergina N, Lim L, Goga A, Moasser MM.

Biochem J. 2012 Nov 1;447(3):417-25. doi: 10.1042/BJ20120724.

11.

Role of procalcitonin in managing adult patients with respiratory tract infections.

Schuetz P, Amin DN, Greenwald JL.

Chest. 2012 Apr;141(4):1063-1073. doi: 10.1378/chest.11-2430. Review.

PMID:
22474148
12.

Distinct Toll-like receptor signals regulate cerebral parasite load and interferon α/β and tumor necrosis factor α-dependent T-cell infiltration in the brains of Trypanosoma brucei-infected mice.

Amin DN, Vodnala SK, Masocha W, Sun B, Kristensson K, Rottenberg ME.

J Infect Dis. 2012 Jan 15;205(2):320-32. doi: 10.1093/infdis/jir734. Epub 2011 Nov 23.

13.

Chemoreceptors in signalling complexes: shifted conformation and asymmetric coupling.

Amin DN, Hazelbauer GL.

Mol Microbiol. 2010 Dec;78(5):1313-23. doi: 10.1111/j.1365-2958.2010.07408.x. Epub 2010 Oct 12.

14.

The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics.

Amin DN, Campbell MR, Moasser MM.

Semin Cell Dev Biol. 2010 Dec;21(9):944-50. doi: 10.1016/j.semcdb.2010.08.007. Epub 2010 Sep 9. Review.

15.

Identification of stage biomarkers for human African trypanosomiasis.

Amin DN, Ngoyi DM, Nhkwachi GM, Palomba M, Rottenberg M, Büscher P, Kristensson K, Masocha W.

Am J Trop Med Hyg. 2010 Jun;82(6):983-90. doi: 10.4269/ajtmh.2010.09-0770.

16.

Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.

Coma S, Amin DN, Shimizu A, Lasorella A, Iavarone A, Klagsbrun M.

Cancer Res. 2010 May 1;70(9):3823-32. doi: 10.1158/0008-5472.CAN-09-3048. Epub 2010 Apr 13.

17.

Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.

Amin DN, Sergina N, Ahuja D, McMahon M, Blair JA, Wang D, Hann B, Koch KM, Shokat KM, Moasser MM.

Sci Transl Med. 2010 Jan 27;2(16):16ra7. doi: 10.1126/scitranslmed.3000389.

18.

The chemoreceptor dimer is the unit of conformational coupling and transmembrane signaling.

Amin DN, Hazelbauer GL.

J Bacteriol. 2010 Mar;192(5):1193-200. doi: 10.1128/JB.01391-09. Epub 2010 Jan 8.

19.

Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis.

Amin DN, Rottenberg ME, Thomsen AR, Mumba D, Fenger C, Kristensson K, Büscher P, Finsen B, Masocha W.

J Infect Dis. 2009 Nov 15;200(10):1556-65. doi: 10.1086/644597.

PMID:
19827943
20.

Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin.

Vodnala SK, Ferella M, Lundén-Miguel H, Betha E, van Reet N, Amin DN, Oberg B, Andersson B, Kristensson K, Wigzell H, Rottenberg ME.

PLoS Negl Trop Dis. 2009 Aug 4;3(8):e495. doi: 10.1371/journal.pntd.0000495.

21.

Differential invasion of Trypanosoma brucei brucei and lymphocytes into the brain of C57BL/6 and 129Sv/Ev mice.

Masocha W, Amin DN, Kristensson K, Rottenberg ME.

Scand J Immunol. 2008 Nov;68(5):484-91. doi: 10.1111/j.1365-3083.2008.02170.x. Epub 2008 Sep 15.

22.

Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells.

Amin DN, Bielenberg DR, Lifshits E, Heymach JV, Klagsbrun M.

Microvasc Res. 2008 May;76(1):15-22. doi: 10.1016/j.mvr.2008.01.002. Epub 2008 Mar 18.

PMID:
18440031
23.

Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion.

Amin DN, Masocha W, Ngan'dwe K, Rottenberg M, Kristensson K.

Acta Trop. 2008 Apr;106(1):72-4. doi: 10.1016/j.actatropica.2008.01.005. Epub 2008 Feb 2.

PMID:
18329619
24.

Organization of the aerotaxis receptor aer in the membrane of Escherichia coli.

Amin DN, Taylor BL, Johnson MS.

J Bacteriol. 2007 Oct;189(20):7206-12. Epub 2007 Aug 10.

25.

Glossina proteolytic lectin does not require a carbohydrate moiety for enzymatic or trypanosome-transforming activities.

Amin DN, Kamita SG, Muluvi GM, Machuka J, Hammock BD, Osir EO.

J Med Entomol. 2006 Mar;43(2):301-8.

PMID:
16619615
26.
27.

Topology and boundaries of the aerotaxis receptor Aer in the membrane of Escherichia coli.

Amin DN, Taylor BL, Johnson MS.

J Bacteriol. 2006 Feb;188(3):894-901.

28.

Neuregulin-regulated gene expression in mammary carcinoma cells.

Amin DN, Tuck D, Stern DF.

Exp Cell Res. 2005 Sep 10;309(1):12-23.

PMID:
15963498
29.

Tumor-associated endothelial cells with cytogenetic abnormalities.

Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M.

Cancer Res. 2004 Nov 15;64(22):8249-55.

30.

Gene expression profiling of ErbB receptor and ligand-dependent transcription.

Amin DN, Perkins AS, Stern DF.

Oncogene. 2004 Feb 19;23(7):1428-38.

PMID:
14973552
31.

Positive Kveim test in patients with coexisting sarcoidosis and human immunodeficiency virus infection.

Amin DN, Sperber K, Brown LK, Chusid ED, Teirstein AS.

Chest. 1992 May;101(5):1454-6.

PMID:
1582320
32.

Functional antagonism between hormone receptor systems: modulation of glycoprotein secretion in secretory epithelial cells.

Amin DN, Goswami S, Klein T, Maayani S, Marom Z.

Am J Respir Cell Mol Biol. 1991 Feb;4(2):135-9.

PMID:
1671333
33.

Propranolol administration in theophylline overdose.

Amin DN, Henry JA.

Lancet. 1985 Mar 2;1(8427):520-1. No abstract available.

PMID:
2857884

Supplemental Content

Support Center